Cold & Flu — the respiratory group
How cold and flu viruses work.
Cold and flu viruses primarily target the upper respiratory tract. They bind to cells in the mucous membranes of the nose, throat, and airways — and begin replicating there. The body responds by launching an immune response, which produces most of the familiar symptoms: fever, fatigue, sore throat, runny nose.
The faster and more effectively the immune system responds, the shorter and milder the illness tends to be. This is where ascorbic acid plays a primary role.
COVID-19 — a virus that plays two games
COVID-19 is different.
COVID-19 is unusual because it combines two mechanisms.
Like flu, it infects the respiratory tract — and here ascorbic acid's immune-supporting role is directly relevant.
But COVID-19 also binds to ACE2 receptors present on endothelial cells — the cells lining blood vessel walls. This triggers inflammation of the vessels themselves, and in serious cases leads to vascular damage, clotting problems, and the conditions behind "long COVID."
This is where rutin becomes relevant — for exactly the same reason it is studied in the context of hantavirus and Ebola.
COVID-19 sits at the intersection of two groups:
It is a respiratory virus — like cold and flu — where ascorbic acid plays a primary role.
It is also a vascular threat — like hantavirus and Ebola — where rutin's vessel-supporting properties become relevant.
For the vascular mechanism in more detail: See what the science says — Hantavirus, Ebola & Vascular Threats →
Summary
The picture in one table.
| Virus | Primary mechanism | Key compound |
|---|---|---|
| Common cold | Respiratory — suppresses immune defences | Ascorbic acid |
| Influenza | Respiratory — depletes immune resources | Ascorbic acid |
| COVID-19 | Respiratory + vascular | Ascorbic acid + Rutin |
Scientific references
pubmed.ncbi.nlm.nih.gov/28353648/
ncbi.nlm.nih.gov/pmc/articles/PMC5707683/